Disc Medicine, Inc.

Healthcare · Biotechnology · United States

Last price 82.84 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 3.68B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Disc Medicine, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States. The company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, primarily heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for the tre...